Bionano Genomics, Inc.
BNGO
$4.08
-$0.02-0.49%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 40.26% | -39.30% | -62.26% | -75.34% | -94.47% |
| Total Depreciation and Amortization | 17.90% | 13.37% | 26.63% | 41.38% | 46.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -67.36% | 278.83% | 294.85% | 317.98% | 453.90% |
| Change in Net Operating Assets | 71.82% | 80.85% | 70.34% | 47.14% | 43.43% |
| Cash from Operations | 29.04% | 20.98% | 3.08% | -0.29% | -12.08% |
| Capital Expenditure | 64.74% | 64.77% | 47.36% | 47.16% | 15.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 100.00% |
| Cash Acquisitions | 100.00% | 100.00% | 100.31% | 100.31% | 35.43% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -86.92% | -44.55% | -44.22% | -77.91% | 316.04% |
| Cash from Investing | -83.03% | -17.35% | -17.99% | -70.81% | 526.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -165,938.64% | -170,763.41% | -120,200.00% | -25,030.56% | -102.22% |
| Issuance of Common Stock | 5.02% | -9.05% | 49.31% | 144.81% | 98.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5,004.31% | 4,177.10% | 6,888.00% | 11,351.73% | -100.87% |
| Cash from Financing | 11.94% | 3.49% | 104.25% | 394.70% | 83.17% |
| Foreign Exchange rate Adjustments | -56.31% | 200.00% | 250.00% | 271.05% | 183.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -478.92% | 155.25% | 159.63% | 167.38% | 106.04% |
